Suppr超能文献

用于集成式内耳药物递送平台的微纳加工注入-抽出微型泵组件。

Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform.

作者信息

Tandon Vishal, Kang Woo Seok, Spencer Abigail J, Kim Ernest S, Pararas Erin E L, McKenna Michael J, Kujawa Sharon G, Mescher Mark J, Fiering Jason, Sewell William F, Borenstein Jeffrey T

机构信息

Charles Stark Draper Laboratory, Cambridge, MA, 02139, England.

出版信息

Biomed Microdevices. 2015 Apr;17(2):37. doi: 10.1007/s10544-014-9923-8.

Abstract

One of the major challenges in treatment of auditory disorders is that many therapeutic compounds are toxic when delivered systemically. Local intracochlear delivery methods are becoming critical in emerging treatments and in drug discovery. Direct infusion via cochleostomy, in particular, is attractive from a pharmacokinetics standpoint, as there is potential for the kinetics of delivery to be well-controlled. Direct infusion is compatible with a large number of drug types, including large, complex molecules such as proteins and unstable molecules such as siRNA. In addition, hair-cell regeneration therapy will likely require long-term delivery of a timed series of agents. This presents unknown risks associated with increasing the volume of fluid within the cochlea and mechanical damage caused during delivery. There are three key requirements for an intracochlear drug delivery system: (1) a high degree of miniaturization (2) a method for pumping precise and small volumes of fluid into the cochlea in a highly controlled manner, and (3) a method for removing excess fluid from the limited cochlear fluid space. To that end, our group is developing a head-mounted microfluidics-based system for long-term intracochlear drug delivery. We utilize guinea pig animal models for development and demonstration of the device. Central to the system is an infuse-withdraw micropump component that, unlike previous micropump-based systems, has fully integrated drug and fluid storage compartments. Here we characterize the infuse-withdraw capabilities of our micropump, and show experimental results that demonstrate direct drug infusion via cochleostomy in animal models. We utilized DNQX, a glutamate receptor antagonist that suppresses CAPs, as a test drug. We monitored the frequency-dependent changes in auditory nerve CAPs during drug infusion, and observed CAP suppression consistent with the expected drug transport path based on the geometry and tonotopic organization of the cochlea.

摘要

治疗听觉障碍的主要挑战之一是,许多治疗性化合物经全身给药时具有毒性。局部耳蜗内给药方法在新兴治疗和药物研发中变得至关重要。特别是通过蜗窗造口术进行直接输注,从药代动力学角度来看很有吸引力,因为给药动力学有可能得到很好的控制。直接输注与大量药物类型兼容,包括蛋白质等大分子和小干扰RNA等不稳定分子。此外,毛细胞再生疗法可能需要长期定时递送一系列药物。这带来了与耳蜗内液体量增加相关的未知风险以及递送过程中造成的机械损伤。耳蜗内药物递送系统有三个关键要求:(1)高度小型化;(2)一种以高度可控的方式将精确且少量的液体泵入微耳的方法;(3)一种从有限的耳蜗液空间中去除多余液体的方法。为此,我们团队正在开发一种基于微流控技术的头戴式系统,用于长期耳蜗内药物递送。我们利用豚鼠动物模型来开发和演示该装置。该系统的核心是一个注入-抽出微泵组件,与以前基于微泵的系统不同之处在于,它具有完全集成的药物和液体储存隔室。在此,我们对微泵的注入-抽出能力进行了表征,并展示了在动物模型中通过蜗窗造口术进行直接药物输注的实验结果。我们使用了抑制复合动作电位(CAPs)的谷氨酸受体拮抗剂DNQX作为测试药物。在药物输注过程中,我们监测了听神经复合动作电位随频率的变化,并观察到复合动作电位受到抑制,这与基于耳蜗的几何结构和音频定位组织所预期的药物传输路径一致。

相似文献

1
Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform.
Biomed Microdevices. 2015 Apr;17(2):37. doi: 10.1007/s10544-014-9923-8.
3
Development of a microfluidics-based intracochlear drug delivery device.
Audiol Neurootol. 2009;14(6):411-22. doi: 10.1159/000241898. Epub 2009 Nov 16.
4
Local drug delivery with a self-contained, programmable, microfluidic system.
Biomed Microdevices. 2009 Jun;11(3):571-8. doi: 10.1007/s10544-008-9265-5.
5
Intracochlear drug delivery systems.
Expert Opin Drug Deliv. 2011 Sep;8(9):1161-74. doi: 10.1517/17425247.2011.588207. Epub 2011 May 26.
7
A nanoliter resolution implantable micropump for murine inner ear drug delivery.
J Control Release. 2019 Mar 28;298:27-37. doi: 10.1016/j.jconrel.2019.01.032. Epub 2019 Jan 25.
9
Kinetics of reciprocating drug delivery to the inner ear.
J Control Release. 2011 Jun 10;152(2):270-7. doi: 10.1016/j.jconrel.2011.02.021. Epub 2011 Mar 6.
10
The role of intracochlear drug delivery devices in the management of inner ear disease.
Expert Opin Drug Deliv. 2015 Mar;12(3):465-79. doi: 10.1517/17425247.2015.974548. Epub 2014 Oct 27.

引用本文的文献

1
Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear.
Front Pharmacol. 2023 Oct 19;14:1207141. doi: 10.3389/fphar.2023.1207141. eCollection 2023.
2
Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss.
Theranostics. 2023 Jun 19;13(11):3524-3549. doi: 10.7150/thno.83383. eCollection 2023.
3
Nanoparticles for the Treatment of Inner Ear Infections.
Nanomaterials (Basel). 2021 May 17;11(5):1311. doi: 10.3390/nano11051311.
4
[Development of novel drug carrier via round window membrane].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):380-384. doi: 10.13201/j.issn.2096-7993.2021.04.022.
5
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear.
Drug Deliv Transl Res. 2022 Jan;12(1):257-266. doi: 10.1007/s13346-021-00914-9. Epub 2021 Feb 4.
6
Prospects and Opportunities for Microsystems and Microfluidic Devices in the Field of Otorhinolaryngology.
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):29-42. doi: 10.21053/ceo.2020.00626. Epub 2020 Aug 11.
7
A nanoliter resolution implantable micropump for murine inner ear drug delivery.
J Control Release. 2019 Mar 28;298:27-37. doi: 10.1016/j.jconrel.2019.01.032. Epub 2019 Jan 25.

本文引用的文献

1
Sound strategies for hearing restoration.
Science. 2014 May 9;344(6184):1241062. doi: 10.1126/science.1241062.
4
Kinetics of reciprocating drug delivery to the inner ear.
J Control Release. 2011 Jun 10;152(2):270-7. doi: 10.1016/j.jconrel.2011.02.021. Epub 2011 Mar 6.
6
Drug delivery for treatment of inner ear disease: current state of knowledge.
Ear Hear. 2010 Apr;31(2):156-65. doi: 10.1097/AUD.0b013e3181c351f2.
7
Development of a microfluidics-based intracochlear drug delivery device.
Audiol Neurootol. 2009;14(6):411-22. doi: 10.1159/000241898. Epub 2009 Nov 16.
8
Therapeutic regulation of gene expression in the inner ear using RNA interference.
Adv Otorhinolaryngol. 2009;66:13-36. doi: 10.1159/000218205. Epub 2009 Jun 2.
9
Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.
Biomaterials. 2009 May;30(13):2614-24. doi: 10.1016/j.biomaterials.2009.01.015. Epub 2009 Jan 29.
10
Local drug delivery with a self-contained, programmable, microfluidic system.
Biomed Microdevices. 2009 Jun;11(3):571-8. doi: 10.1007/s10544-008-9265-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验